News | May 24, 2024
BaseLaunch announces a new partnership with AbbVie
Further strengthens BaseLaunch's global pharma industry partnerships
Further strengthens BaseLaunch's global pharma industry partnerships
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
Investing in Malaysia's largest clinic operator to expand the healthcare business
Sales reflect continued strong growth in oncology and vaccines
Acquisition of exclusive commercialization rights for European markets
iSolveSM information on demand is the result of our focus on customer relationship
An accomplished R&D leader and champion of the application of AI to drug discovery
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Subscribe To Our Newsletter & Stay Updated
